by Karen O'Hanlon Cohrt | Feb 18, 2024 | Trends
Organoids are cell-derived, 3D in vitro models that are cultured to recapitulate structural and functional aspects of the in vivo tissue they are intended to represent. Organoids are not new to research labs, although there has been much hype about them in recent...
by Karen O'Hanlon Cohrt | Sep 24, 2023 | Disease Models
In our last few liver articles, we highlighted the urgent need for new models and treatments for non-alcoholic steatohepatitis (NASH), and looked at the potential for human liver organoids to not only model disease, but also to test new drugs for safety and efficacy....
by Angela L. Huang | Mar 15, 2023 | News
SAN FRANCISCO, CA —Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived cell products and affiliated cell-based services in the following...
by Allison Kennedy | Feb 17, 2023 | Industry News
In an article published in genengnews.com, the findings of a research study “Topological Morphogenesis of Neuroepithelial Organoids” discovered new information about cell-to-cell tissue connectivity that provides an organizational backbone for further organ...
by Karen O'Hanlon Cohrt | Apr 11, 2018 | Trends
In the modern fast-paced worlds of research and medicine, disease models that take us closer to the real-life situation are highly desirable. While we can’t discredit the power of in vitro cell culture methods to provide important clues about biological processes,...
